🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This is a Phase II study following subjects proceeding with our Institution...
Status
Recruiting
Location
Masonic Cancer Center at University of Minnesota
Start Date
2023-05-01
Trial ID
NCT05805605
The goal of this clinical research study is to learn if treating umbilical ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00972101
This is a a phase 1, open label study to assess the safety and efficacy of ...
Status
Unknown
Location
Henan cancer hospital
Start Date
2022-12-01
Trial ID
NCT05640713
Treatments Being Tested
The goal of this clinical research study is to learn if fludarabine, melpha...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2005-07
Trial ID
NCT00385788
This study is designed to compare progression-free survival (PFS) from rand...
Status
Completed
Location
University of Alabama
Start Date
2015-08
Trial ID
NCT02440464
Treatments Being Tested
The goal of this clinical trial is to learn if Revumenib in combination wit...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-31
Trial ID
NCT07686107